Rising Demand for Hypertension Drug Market Key Players, Growth Analysis during 2021-2027
The global hypertension drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Hypertension is a common condition which occurred due to the long-term force of the blood against the artery walls. Additionally, it is marked by high blood pressure and can also cause health problems, such as heart disease. The major factor driving the demand for the global hypertension drug market during the forecast period is the increasing prevalence of hypertension across the globe.
To Request a Sample of our Report on Hypertension Drug
Market: https://www.omrglobal.com/request-sample/hypertension-drug-market
According to the Center for
Disease Control and Prevention, nearly half of adults or 47%, or 116 million
have hypertension which is defined as a systolic blood pressure greater than
130 mmHg or diastolic blood pressure greater than 80 mmHg or are taking medication
for hypertension in the US. Additionally, about 1 in 4 adults (24%) with
hypertension have their condition under control and about half of the adults or
45% or 37 million with uncontrolled hypertension have a blood pressure of
140/90 mmHg or higher in the US. Furthermore, about 34 million adults are
recommended to take medication and about two out of three of this group or 19
million have a blood pressure of 140/90 mmHg or higher. Hence, the increasing
prevalence of hypertension is driving the demand for hypertension drugs which
in turn is driving the growth of the market.
Some major players in the market
include GlaxoSmithKline plc, Sanofi S.A., and Novartis International among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in December
2021, Dr Reddy's Laboratories announced the launch of Valsartan tablets which
is the therapeutic equivalent of Diovan in the US market, It is used for the
treatment of high blood pressure and heart failure.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Drug Class
·
By Distribution Channel
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- GlaxoSmithKline plc, Sanofi
S.A., and Novartis International among others.
(Get 15% Discount on Buying this Report)
A
full Report of Hypertension Drug Market is Available @ https://www.omrglobal.com/industry-reports/hypertension-drug-market
Global Hypertension Drug Market Report by Segment
By Drug Class
·
Diuretics
·
ACE Inhibitors
·
Calcium Channel Blockers
·
Vasodilators
·
Beta-adrenergic Blockers
·
Others
By Distribution Channel
·
Retail Pharmacy
·
Hospital Pharmacy
·
E-commerce
Global Hypertension Drug Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment